Twist Bioscience Announces Proposed Public Offering of Common Stock

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has commenced an underwritten public offering of 3,000,000 shares of its common stock.